|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.750 SEK | +0.57% |
|
-0.34% | -35.19% |
| 07/07 | Vivesto chairman Peter Zonabend increases his shareholding | FW |
| 01/07 | Vivesto Completes Enrollment in Cat Study of Paccal Vet | FW |
| Market Cap | 9.69Cr 99.92L 87.69L 81.66L 75.1L 1.41Cr 95Cr 1.43Cr 3.79Cr 47Cr 3.75Cr 3.67Cr 163.56Cr | P/E 2026 * |
-2.86x | P/E 2027 * | -2.09x |
|---|---|---|---|---|---|
| Enterprise Value | 8.89Cr 91.67L 80.45L 74.91L 68.9L 1.29Cr 88Cr 1.31Cr 3.48Cr 43Cr 3.44Cr 3.37Cr 150.06Cr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
56.4% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vivesto AB
| 1 day | +0.57% | ||
| 1 week | -0.34% | ||
| Current month | +2.94% | ||
| 1 month | +1.86% | ||
| 3 months | +6.45% | ||
| 6 months | -8.85% | ||
| Current year | -35.19% |
| 1 week | 8.26 |  | 8.85 |
| 1 month | 7.6 | | 9.18 |
| Current year | 7 | | 19.5 |
| 1 year | 7 | | 31.9 |
| 3 years | 7 | | 90.6 |
| 5 years | 7 | | 303.2 |
| 10 years | 7 | | 1,670 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Kinnman
CEO | Chief Executive Officer | 68 | 23/01/2023 |
Björn Svanström
DFI | Director of Finance/CFO | 55 | 01/07/2026 |
| Chief Tech/Sci/R&D Officer | 39 | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 46 | 25/05/2022 | |
Hege Hellstrom
BRD | Director/Board Member | 61 | 26/09/2019 |
Pål Ryfors
BRD | Director/Board Member | 43 | 25/05/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/03/22 | Buy | Chief Executive Officer | 12,200 | 0.0027% | ||
| 24/03/22 | Others | Chairman | 1,20,000 | 0.0268% | ||
| 20/12/21 | Free | Chief Financial Officer | 13,50,000 | 0.3011% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.57% | -0.34% | -62.61% | -66.92% | 99.92L | |
| +1.93% | +3.85% | +51.05% | +166.24% | 1,08900Cr | |
| +0.29% | +6.43% | +60.47% | +52.87% | 64TCr | |
| +2.45% | +2.77% | +39.61% | +74.48% | 47TCr | |
| +2.17% | +10.22% | +41.17% | +36.56% | 36TCr | |
| +1.46% | +3.87% | +39.70% | +44.49% | 30TCr | |
| +0.40% | +3.59% | +19.93% | +17.02% | 27TCr | |
| +2.73% | +3.50% | -25.66% | -36.53% | 23TCr | |
| +4.48% | +7.33% | +30.47% | +66.31% | 21TCr | |
| +2.91% | +3.10% | +18.84% | +74.76% | 17TCr | |
| Average | +2.02% | +4.53% | +21.30% | +42.93% | 37.31TCr | |
| Weighted average by Cap. | +1.97% | +5.14% | +39.89% | +80.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -3.1Cr -31.97L -28.06L -26.13L -24.03L -45.05L -31Cr -45.83L -1.21Cr -15Cr -1.2Cr -1.17Cr -52Cr | -4.6Cr -47.45L -41.64L -38.77L -35.66L -66.85L -45Cr -68L -1.8Cr -22Cr -1.78Cr -1.74Cr -78Cr |
| Net Debt | -80L -8L -7L -7L -6L -11.63L -7.88Cr -11.83L -31.31L -3.91Cr -30.98L -30.31L -14Cr | -1Cr -10.31L -9L -8L -8L -14.53L -9.85Cr -14.78L -39.14L -4.89Cr -38.72L -37.89L -17Cr |
Employees
4
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | SEK 8.750 | +0.57% | 9,172 |
| 27/26/27 | SEK 8.700 | -1.69% | 8,819 |
| 24/26/24 | SEK 8.850 | +0.68% | 4,294 |
| 23/26/23 | SEK 8.790 | +2.21% | 4,329 |
| 22/26/22 | SEK 8.600 | -2.05% | 3,443 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VIVE Stock
Select your edition
All financial news and data tailored to specific country editions
